Analysis of the adaptor function of the LIM domain-containing protein FHL2 using an affinity chromatography approach

被引:9
|
作者
El Mourabit, H
Müller, S
Tunggal, L
Paulsson, M
Aumailley, M
机构
[1] Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany
[2] Univ Cologne, Fac Med, Ctr Mol Med, D-50931 Cologne, Germany
关键词
FHL2; LIM domain; lamellipodia; proteomics; MALDI-TOF; mass spectrometry;
D O I
10.1002/jcb.20096
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Containing four LIM domains and an N-terminal half LIM domain, FHL2 has been predicted to have an adaptor function in the formation of higher order molecular complexes in the nucleus and the cytoplasm of cells. We expressed recombinant FHL2 in insect cells using; the baculovirus system and used it to isolate director indirect interaction partners from the cytosolic fraction of fibroblasts by affinity chromatography. These were identified by their peptide mass fingerprints using MALDI-TOF mass spectrometry. Cytoskeleton-associated proteins present among the bound proteins were shown to co-localise with FHL2 in cell lamellipodia by indirect immunofluorescence staining. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:612 / 625
页数:14
相关论文
共 50 条
  • [21] Cypher, a striated muscle-restricted PDZ and LIM domain-containing protein, binds to α-actinin-2 and protein kinase C
    Zhou, Q
    Ruiz-Lozano, P
    Martone, ME
    Chen, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (28) : 19807 - 19813
  • [22] Four-and-a-Half LIM-Domain Protein 2 (FHL2) Induces Neuropeptide Y (NPY) in Macrophages in Visceral Adipose Tissue and Promotes Diet-Induced Obesity
    Sommer, Judith
    Ehnis, Hanna
    Seitz, Tatjana
    Schneider, Julia
    Wild, Andreas B.
    Moceri, Sandra
    Buechler, Christa
    Bozec, Aline
    Weber, Georg F.
    Merkel, Susanne
    Beckervordersandforth, Ruth
    Steinkasserer, Alexander
    Schuele, Roland
    Trebicka, Jonel
    Hartmann, Arndt
    Bosserhoff, Anja
    von Hoersten, Stephan
    Dietrich, Peter
    Hellerbrand, Claus
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (19)
  • [23] EH domain-containing protein 2 (EHD2): Overview, biological function, and therapeutic potential
    Zhu, Guoqiang
    Zhang, Hu
    Xia, Min
    Liu, Yiqi
    Li, Mingyong
    CELL BIOCHEMISTRY AND FUNCTION, 2024, 42 (03)
  • [24] Allelic exclusion of the T cell receptor β locus requires the SH2 domain-containing leukocyte protein (SLP)-76 adaptor protein
    Aifantis, I
    Pivniouk, VI
    Gärtner, F
    Feinberg, J
    Swat, W
    Alt, FW
    von Boehmer, H
    Geha, RS
    JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (08): : 1093 - 1102
  • [25] X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein
    Schuster, V
    Kreth, HW
    IMMUNOLOGICAL REVIEWS, 2000, 178 : 21 - 28
  • [26] A Yersinia ruckeri TIR Domain-Containing Protein (STIR-2) Mediates Immune Evasion by Targeting the MyD88 Adaptor
    Liu, Tao
    Wei, Wen-Yan
    Wang, Kai-Yu
    Wang, Er-Long
    Yang, Qian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (18)
  • [27] Gads is a novel SH2 and SH3 domain-containing adaptor protein that binds to tyrosine-phosphorylated Shc
    Liu, SK
    McGlade, CJ
    ONCOGENE, 1998, 17 (24) : 3073 - 3082
  • [28] Gads is a novel SH2 and SH3 domain-containing adaptor protein that binds to tyrosine-phosphorylated Shc
    Stanley K Liu
    C Jane McGlade
    Oncogene, 1998, 17 : 3073 - 3082
  • [29] Biochemical, structural and physiological analysis of the SPRY domain-containing SOCS box protein 2 (SSB-2)
    Masters, SL
    Yao, S
    Palmer, KR
    Zhang, JG
    Sprigg, NS
    Nicola, NA
    Norton, RS
    Nicholson, SE
    FEBS JOURNAL, 2005, 272 : 14 - 14
  • [30] Epigenetic repression of PDZ-LIM domain-containing protein 2 promotes ovarian cancer via NOS2-derived nitric oxide signaling
    Zhao, Linjie
    Yu, Chuan
    Zhou, Shengtao
    Lau, Wayne Bond
    Lau, Bonnie
    Luo, Zhongyue
    Lin, Qiao
    Yang, Huiliang
    Xuan, Yu
    Yi, Tao
    Zhao, Xia
    Wei, Yuquan
    ONCOTARGET, 2016, 7 (02) : 1408 - 1420